Gosselies-based healthtech company OncoDNA has raised €19m (US$20m) Series B funding led by Vesalius Biocapital III and Swisscanto Invest by Zürcher Kantonalbank. “We are delighted to have successfully raised sufficient…
Gosselies-based healthtech company OncoDNA has raised €19m (US$20m) Series B funding led by Vesalius Biocapital III and Swisscanto Invest by Zürcher Kantonalbank. “We are delighted to have successfully raised sufficient…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference